Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.
about
A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies.Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime.Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.A fast method for testing covariates in population PK/PD ModelsInfluences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.Concordance between criteria for covariate model building.A population pharmacokinetic model for docetaxel (Taxotere): model building and validation.Population analysis of once-daily dosing of gentamicin in patients with neutropenia.Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis.Relationship between clinical and biologic variables and chloramphenicol pharmacokinetic parameters in pediatric patients with sepsis.
P2860
Q30983125-604A0201-D0EB-44C2-9B88-636D15F4B205Q34739682-3532F73E-0B16-48E8-9BCC-FAFB9AF945D0Q35126112-C2D7EF65-4E52-41DB-8F5D-C89E90319BBDQ36628026-96FE5616-FEA5-4D1A-8921-374847DA8F86Q37361810-1FA0E49A-B1B2-4F07-8D40-C2C4C4E685F1Q38137251-C710A803-5CF8-4F65-99FA-55E59FAF4C8BQ38254598-ED070344-FCD4-435A-BBE9-841A07F873B4Q38610672-55D50E25-7333-43BB-8E3E-CE02763090A2Q42578169-67DE1366-C0DB-4E45-8D2B-E09E25FD1821Q45343385-2D623D66-9953-4C4E-A464-F0D7D679C50CQ46171352-B7F0A0A5-4F97-4602-861C-35706AE24E66Q50875106-12E4D28F-F31B-40B9-9356-C2440E2FBA9AQ52069381-18672AE2-5894-42D4-BDF0-BDCA06B771D3Q52075872-B4AF655D-F9E4-4C6D-8600-26E732A3955F
P2860
Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Evaluation of Bayesian estimat ...... intensive care unit patients.
@ast
Evaluation of Bayesian estimat ...... intensive care unit patients.
@en
type
label
Evaluation of Bayesian estimat ...... intensive care unit patients.
@ast
Evaluation of Bayesian estimat ...... intensive care unit patients.
@en
prefLabel
Evaluation of Bayesian estimat ...... intensive care unit patients.
@ast
Evaluation of Bayesian estimat ...... intensive care unit patients.
@en
P2093
P2860
P921
P356
P1476
Evaluation of Bayesian estimat ...... intensive care unit patients.
@en
P2093
Ballereau M
Iliadis MC
Lacarelle B
Mandema JW
P2860
P2888
P304
P356
10.1007/BF01064424
P577
1992-12-01T00:00:00Z
P6179
1016770282